• Citer

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

par Dieci, Maria Vittoria;Radosevic-Robin, Nina;Fineberg, Susan;Van den Eynden, Gert;Ternes, Nils;Pénault-Llorca, Frederique;Pruneri, Giancarlo;D'Alfonso, Timothy TM;Demaria, Sandra;Castaneda, Carlos;Sanchez, Joselyn;Badve, Sunil;Michiels, Stefan ;Bossuyt, Veerle Ilse Julie;Rojo, Federico;Singh, Baljit;Nielsen, Torsten;Viale, Giuseppe;Kim, Seong-Rim;Hewitt, Stephen M;Wienert, Stephan;Loibl, Sibylle;Rimm, David D.L.;Symmans, Fraser;Denkert, Carsten;Adams, Sylvia;Loi, Sherene ;Salgado, Roberto;International Immuno-Oncology Biomarker Working Group on Breast Cancer,
Référence Seminars in cancer biology, 52, Pt 2, page (16-25)
Publication Publié, 2018

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Auteur:	Dieci, Maria Vittoria; Radosevic-Robin, Nina; Fineberg, Susan; Van den Eynden, Gert; Ternes, Nils; Pénault-Llorca, Frederique; Pruneri, Giancarlo; D'Alfonso, Timothy TM; Demaria, Sandra; Castaneda, Carlos; Sanchez, Joselyn; Badve, Sunil; Michiels, Stefan; Bossuyt, Veerle Ilse Julie; Rojo, Federico; Singh, Baljit; Nielsen, Torsten; Viale, Giuseppe; Kim, Seong-Rim; Hewitt, Stephen M; Wienert, Stephan; Loibl, Sibylle; Rimm, David D.L.; Symmans, Fraser; Denkert, Carsten; Adams, Sylvia; Loi, Sherene; Salgado, Roberto; International Immuno-Oncology Biomarker Working Group on Breast Cancer,
Informations sur la publication:	Seminars in cancer biology, 52, Pt 2, page (16-25)
Statut de publication:	Publié, 2018
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Breast cancer
	Ductal carcinoma in situ
	Neoadjuvant
	Residual cancer burden
	Residual disease
	Tumor-infiltrating lymphocytes
MeSH keywords:	Biomarkers, Tumor -- immunology
	Breast Neoplasms -- immunology
	Carcinoma in Situ -- immunology
	Female
	Humans
	Lymphocytes, Tumor-Infiltrating -- immunology
	Medical Oncology -- methods
	Neoadjuvant Therapy -- methods
	Neoplasm, Residual -- immunology
Langue:	Anglais
Identificateurs:	urn:issn:1044-579X
	info:doi/10.1016/j.semcancer.2017.10.003
	info:pii/S1044-579X(17)30217-1
	info:pmid/29024776